Impact of Vitamin D Receptor Gene Polymorphisms (TaqI and BsmI) on the Incidence and Severity of Coronary Artery Disease: a Report from Southern Iran

Overview

Journal BMC Cardiovasc Disord

Publisher Biomed Central

Specialty Cardiology & Vascular Diseases

Date 2023 Mar 7

PMID 36882686

Authors

Boshra Akhlaghi

Negar Firouzabadi

Farzaneh Foroughinia

Marzieh Nikparvar

Pouyan Dehghani

Affiliations

Soon will be listed here.

Abstract

Background: The association of vitamin D level and vitamin D receptor (VDR) gene polymorphisms with the prevalence of coronary artery disease (CAD) has been evaluated in various studies; however, the reported results were inconsistent. Hence, we aimed to investigate the impact of two VDR gene polymorphisms, TaqI (rs731236) and BsmI (rs1544410), on the incidence and severity of CAD in Iranian population.

Methods: Blood samples were collected from 118 CAD patients underwent elective percutaneous coronary intervention (PCI) and 52 control subjects. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was performed for genotyping. SYTNAX score (SS) was calculated as a grading tool for complexity of CAD by an interventional cardiologist.

Results: TaqI polymorphism of VDR was not associated with the incidence of CAD. A significant difference was observed between CAD patients and controls regarding BsmI polymorphism of VDR (p < 0.001). GA and AA genotypes was significantly associated with a decreased risk of CAD (p = 0.01, p-adjusted = 0.01 and p < 0.001, p-adjusted = 0.001 respectively). A allele of BsmI polymorphism was shown to have a protective effect against CAD (p < 0.001, p-adjusted = 0.002). No association was found between TaqI and BsmI polymorphisms of VDR and SS as a measure of CAD severity.

Conclusion: Association of BsmI genotypes with the incidence of CAD revealed that the genetic variation of VDR might play a role in the pathogenesis of CAD.

Citing Articles

Vitamin D and Cardiovascular Diseases: From Physiology to Pathophysiology and Outcomes.

Nardin M, Verdoia M, Nardin S, Cao D, Chiarito M, Kedhi E Biomedicines. 2024; 12(4).

PMID: 38672124 PMC: 11048686. DOI: 10.3390/biomedicines12040768.

Associations between vitamin D status, gene polymorphisms and echocardiographic markers in Polish patients with cardiovascular disease.

Abouzid M, Burchardt P, Kagan L, Glowka F, Karazniewicz-Lada M Future Cardiol. 2024; 20(3):123-135.

PMID: 38597392 PMC: 11216514. DOI: 10.2217/fca-2023-0129.

Association between Vitamin D Receptor Polymorphism and Susceptibility to Oral Lichen Planus and Oral Squamous Cell Carcinoma.

Mohtasham N, Mohajertehran F, Afzaljavan F, Farshbaf A, Maraqehmoqadam K, Tavakoliroodi M Iran J Otorhinolaryngol. 2024; 36(2):381-389.

PMID: 38476562 PMC: 10925961. DOI: 10.22038/IJORL.2024.73925.3489.

The Role of Polymorphism in the Endothelial Homeostasis and Vitamin D Metabolism Genes in the Severity of Coronary Artery Disease.

Ponasenko A, Sinitskaya A, Sinitsky M, Khutornaya M, Barbarash O Biomedicines. 2023; 11(9).

PMID: 37760823 PMC: 10526004. DOI: 10.3390/biomedicines11092382.

References

Li Y, Kong J, Wei M, Chen Z, Liu S, Cao L . 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002; 110(2):229-38. PMC: 151055. DOI: 10.1172/JCI15219. View

Raimondi S, Johansson H, Maisonneuve P, Gandini S . Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis. 2009; 30(7):1170-80. DOI: 10.1093/carcin/bgp103. View

Zhu Y, Li Z, Ding N, Yi H . The association between vitamin D receptor gene polymorphism and susceptibility to hypertension: a meta-analysis. Eur Rev Med Pharmacol Sci. 2019; 23(20):9066-9074. DOI: 10.26355/eurrev_201910_19309. View

Raljevic D, Persic V, Markova-Car E, Cindric L, Miskulin R, Zuvic M . Study of vitamin D receptor gene polymorphisms in a cohort of myocardial infarction patients with coronary artery disease. BMC Cardiovasc Disord. 2021; 21(1):188. PMC: 8052753. DOI: 10.1186/s12872-021-01959-x. View

Mohammad A, Shammo N, Jasem J . Vitamin D status in acute myocardial infarction: a case-control study. Cardiovasc Endocrinol Metab. 2019; 7(4):93-96. PMC: 6739859. DOI: 10.1097/XCE.0000000000000160. View

Holick M . Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-81. DOI: 10.1056/NEJMra070553. View

Foroughinia F, Morovati N, Safari A, Dianatpour M, Jamhiri I, Heydari S . Association between Fok1 and TaqI polymorphisms of vitamin D receptor gene with the severity of stenosis and calcification in carotid bulb in patients with ischemic stroke. J Clin Neurosci. 2022; 97:115-120. DOI: 10.1016/j.jocn.2022.01.009. View

Kunadian V, Ford G, Bawamia B, Qiu W, Manson J . Vitamin D deficiency and coronary artery disease: a review of the evidence. Am Heart J. 2014; 167(3):283-91. DOI: 10.1016/j.ahj.2013.11.012. View

Sokol S, Tsang P, Aggarwal V, Melamed M, Srinivas V . Vitamin D status and risk of cardiovascular events: lessons learned via systematic review and meta-analysis. Cardiol Rev. 2011; 19(4):192-201. DOI: 10.1097/CRD.0b013e31821da9a5. View

10.

Nakhl S, Sleilaty G, Chouery E, Salem N, Chahine R, Fares N . I vitamin D receptor gene polymorphism and serum 25-hydroxyvitamin D in patients with cardiovascular risk. Arch Med Sci Atheroscler Dis. 2020; 4:e298-e303. PMC: 7191939. DOI: 10.5114/amsad.2019.91437. View

11.

Pfeifer M, Begerow B, Minne H, Nachtigall D, Hansen C . Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab. 2001; 86(4):1633-7. DOI: 10.1210/jcem.86.4.7393. View

12.

Libby P, Theroux P . Pathophysiology of coronary artery disease. Circulation. 2005; 111(25):3481-8. DOI: 10.1161/CIRCULATIONAHA.105.537878. View

13.

Ortlepp J, Lauscher J, Hoffmann R, Hanrath P, Joost H . The vitamin D receptor gene variant is associated with the prevalence of type 2 diabetes mellitus and coronary artery disease. Diabet Med. 2001; 18(10):842-5. DOI: 10.1046/j.1464-5491.2001.00585.x. View

14.

Ortlepp J, von Korff A, Hanrath P, Zerres K, Hoffmann R . Vitamin D receptor gene polymorphism BsmI is not associated with the prevalence and severity of CAD in a large-scale angiographic cohort of 3441 patients. Eur J Clin Invest. 2003; 33(2):106-9. DOI: 10.1046/j.1365-2362.2003.01124.x. View

15.

Kulsoom U, Khan A, Saghir T, Nawab S, Tabassum A, Fatima S . Vitamin D receptor gene polymorphism TaqI (rs731236) and its association with the susceptibility to coronary artery disease among Pakistani population. J Gene Med. 2021; 23(12):e3386. DOI: 10.1002/jgm.3386. View

16.

Pilz S, Tomaschitz A, Marz W, Drechsler C, Ritz E, Zittermann A . Vitamin D, cardiovascular disease and mortality. Clin Endocrinol (Oxf). 2011; 75(5):575-84. DOI: 10.1111/j.1365-2265.2011.04147.x. View

17.

Firouzabadi N, Tajik N, Bahramali E, Bakhshandeh H, Maadani M, Shafiei M . Gender specificity of a genetic variant of angiotensin-converting enzyme and risk of coronary artery disease. Mol Biol Rep. 2013; 40(8):4959-65. DOI: 10.1007/s11033-013-2596-1. View

18.

Ferrarezi D, Bellili-Munoz N, Dubois-Laforgue D, Cheurfa N, Lamri A, Reis A . Allelic variations of the vitamin D receptor (VDR) gene are associated with increased risk of coronary artery disease in type 2 diabetics: the DIABHYCAR prospective study. Diabetes Metab. 2013; 39(3):263-70. DOI: 10.1016/j.diabet.2012.11.004. View

19.

Iyngkaran P, Chan W, Liew D, Zamani J, Horowitz J, Jelinek M . Risk stratification for coronary artery disease in multi-ethnic populations: Are there broader considerations for cost efficiency?. World J Methodol. 2019; 9(1):1-19. PMC: 6354077. DOI: 10.5662/wjm.v9.i1.1. View

20.

Kiani A, Mohamadi-Nori E, Vaisi-Raygani A, Tanhapour M, Elahi-Rad S, Bahrehmand F . Vitamin D-binding protein and vitamin D receptor genotypes and 25-hydroxyvitamin D levels are associated with development of aortic and mitral valve calcification and coronary artery diseases. Mol Biol Rep. 2019; 46(5):5225-5236. DOI: 10.1007/s11033-019-04979-1. View